Memorial Sloan Kettering Cancer Center at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Memorial Sloan Kettering Cancer Center brings 7 presentations to IDWeek 2026 in Washington. Its program centres on viral infections in people with blood cancers or transplants, especially cytomegalovirus and other herpesviruses. One study tracks cytomegalovirus infection and disease after treatment with bispecific T-cell engaging antibodies.
| Organization | IDWeek 2026 Attendance |
|---|---|
Memorial Sloan Kettering Cancer Center New York, NY | |
Poster Thu Oct 22 12:15pm–1:30pm Early Access Program (EAP) Experience of Pritelivir in the Treatment of Acyclovir- and Foscarnet-Refractory Herpes Simplex Virus (HSV) Infection in Immunocompromised (IC) Patients Talk Thu Oct 22 2:15pm–2:30pm Cytomegalovirus viremia and disease after CD19 and CD20 Bispecific T-cell–engaging antibodies (BiTE) Transplant and immunocompromised hosts Poster Fri Oct 23 12:15pm–1:30pm Diagnostic Utility of Targeted Next-Generation Sequencing Compared to Standard of Care for Pulmonary Infections in Patients with Hematologic Malignancies Industry Fri Oct 23 6:30pm–7:30pm Navigating Modern CMV Antivirals: Applying Guideline Updates to Clinical Practice Antimicrobials, resistance and stewardshipTransplant and immunocompromised hosts Talk Sat Oct 24 11:20am–11:45am Session Sat Oct 24 1:45pm–3:00pm Viral Infections With Novel Antineoplastic Treatments Transplant and immunocompromised hosts Talk Sat Oct 24 2:35pm–3:00pm Reactivation of HHV-6: Clinical and Diagnostic Challenges Transplant and immunocompromised hosts |
Instantly find 20 buyers from Memorial Sloan Kettering Cancer Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction